Odyssey Health dissolves sports advisory board, provides concussion drug update: Phase I complete, Phase II planned

Odyssey Health, Inc.

Dissolved sports advisory board to eliminate distraction and maintain focus on drug development.
Phase I human trial completed; drug proven safe and well tolerated.
Company plans to initiate Phase II trial to evaluate efficacy and safety in concussed patients.
Company states it has never received government funding; drug development funded by accredited investors.
Intellectual property and rights to the drug purchased on March 1, 2021 from a third party.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.